Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 1
Submit an article Journal homepage
201
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEPreclinical Therapeutics

Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell Growth In Vitro and In Vivo

Su YanCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Haifeng ZhangCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Yufeng XieCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Weihua ShengCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Jim XiangCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Zhenmin YeCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
,
Weichang ChenCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, Canada
&
Jicheng YangCell and Molecular Biology Institute, College of Medicine, Soochow University, Suzhou, China, Digestive Department, the First Affiliated Hospital of Soochow University, Suzhou, China, Department of Oncology and Immunology, University of Saskatchewan, Saskatoon, CanadaCorrespondence[email protected]
 show all
Pages 85-93 | Published online: 16 Nov 2009
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

ABSTRACT

Previous studies have demonstrated that interleukin-24 [IL-24; originally called melanoma differentiation associated gene-7 (mda-7)] as a novel tumor suppressor gene has tumor-suppressive activity against a broad spectrum of human cancers. However, the therapeutic effect of the recombinant human IL-24 (rhIL-24) protein purified from prokaryotic cells on gastric cancer has not been reported. In this study, we purified soluble rhIL-24 using Q-Sepharose column after the denaturing and renaturing process from the protein of Escherichia coli BL21 transfected with pET-21a(+)-hIL-24 vector and treated by isopropyl-β-D-1-thiogalactopyranoside (IPTG) for enhanced expression of transgene rhIL-24. We demonstrated that rhIL-24 was capable of inducing in vitro apoptosis of SGC7901 gastric cancer cells and activating peripheral blood mononuclear cellsto secrete cytokines such as IL-6, TNF-α, and IFN-γ. We also showed that rhIL-24 was able to inhibit formation of blood capillaries on chicken embryonic allantois and in vivo tumor angiogenesis leading to suppressing SGC7901 gastric cancer cell growth in vitro and in vivo possibly due to its downregulation of Bcl-2/Bax ratio, VEGF (vascular endothelial growth factor), and CD34. Therefore, our results indicate that rhIL-24 has potent suppressive effect on human SGC7901 gastric carcinoma cell line and warrant its further investigation for therapeutic application against gastric cancer.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,193.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.